- Home
- CHRS vs CTW Comparison
CHRS vs CTW Comparison
Compare CHRS & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHRS | CTW |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.1M | 171.0M |
| IPO Year | 2014 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CHRS | CTW |
|---|---|---|
| Price | $1.02 | $1.75 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 13.8K |
| Earning Date | 11-05-2026 | 10-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 472.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $44.19 | N/A |
| Revenue Next Year | $65.06 | N/A |
| P/E Ratio | ★ N/A | $22.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.94 | $1.10 |
| 52 Week High | $2.62 | $3.14 |
Technical Indicators
Market Signals| Indicator | CHRS | CTW |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | 37.28 |
| Support Level | $0.97 | $1.19 |
| Resistance Level | $1.53 | $1.88 |
| Average True Range (ATR) | 0.07 | 0.32 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 36.84 | 5.48 |
Price Performance
Historical ComparisonAbout CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
About CTW CTW Cayman Class A Ordinary Shares
CTW operates as a gaming platform company providing instant access to free-to-play, browser-based games inspired by popular Japanese animation, including "So I'm a Spider, So What? Ruler of the Labyrinth, Arifureta: From Commonplace to World's Strongest - Rebellion Soul", and "Queen's Blade Limit Break". CTW delivers these games through its flagship HTML5 platform, G123.jp.